» Authors » R Riikonen

R Riikonen

Explore the profile of R Riikonen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 60
Citations 588
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tormanen S, Lauhkonen E, Riikonen R, Koponen P, Huhtala H, Helminen M, et al.
Allergy . 2017 Nov; 73(4):916-922. PMID: 29105099
Background: Five studies carried out after bronchiolitis at less than 24 months of age, with a follow-up of more than 10 years, reported that atopic dermatitis, family asthma, early-life exposure...
2.
Riikonen R, Mankinen K, Gaily E
Eur J Paediatr Neurol . 2015 Aug; 19(6):647-51. PMID: 26310861
Background: Dose regimens of pyridoxine (vitamin B6) for treatment of infantile spasms have varied from 200 mg/d to 300 mg/kg/d. Only two long-term outcome studies of the treated patients are...
3.
Makkonen I, Kokki H, Kuikka J, Turpeinen U, Riikonen R
Neuropediatrics . 2011 Oct; 42(5):207-9. PMID: 22015434
A positive effect of fluoxetine has been shown in some children with autism. The present study was undertaken to correlate striatal dopamine transporter (DAT) binding and cerebrospinal fluid insulin-like growth...
4.
Pirttila T, Vanhatalo S, Turpeinen U, Riikonen R
Acta Neurol Scand . 2004 Apr; 109(5):337-41. PMID: 15080860
Objectives: Many studies have shown that nitric oxide (NO) and growth factors including insulin growth factors (IGFs) may be involved in the pathogenesis of multiple sclerosis (MS) and neurodegenerative diseases....
5.
Vanhatalo S, Alen R, Riikonen R, Rantala H, Aine M, Mustonen K, et al.
Seizure . 2001 Dec; 10(7):508-11. PMID: 11749108
While vigabatrin-associated visual field constrictions have been generally considered irreversible, some case reports have raised the hope of partial improvement after drug withdrawal in occasional patients. Here we describe seven...
6.
Riikonen R
Brain Dev . 2001 Nov; 23(7):765-9. PMID: 11701291
The progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO) syndrome is a pediatric disorder of unknown origin, characterized by a combination of postnatally progressive encephalopathy, hypsarrhythmia, and optic atrophy....
7.
Riikonen R
Brain Dev . 2001 Nov; 23(7):683-7. PMID: 11701277
The long-term outcome of Finnish children with West syndrome was evaluated. Two hundred and fourteen patients were followed up for 20-35 years or until death. A third of the patients...
8.
Riikonen R
Brain Dev . 2001 Nov; 23(7):642-6. PMID: 11701269
To provide up-to-date information on adrenocorticotropic hormone (ACTH) therapy in the treatment of West syndrome, a review of the Finnish studies was made in answer to the questions: what are...
9.
Riikonen R
Brain Dev . 2001 Nov; 23(7):539-41. PMID: 11701251
The present study examined whether changes in the incidence of West syndrome (WS) could be used to evaluate changes in the quality of prenatal care over time. The incidence of...
10.
Vanhala R, Turpeinen U, Riikonen R
Dev Med Child Neurol . 2001 Sep; 43(9):614-6. PMID: 11570630
Autism is a behaviourally defined syndrome characterized by disturbances of social interaction and communication and restrictions of behaviour patterns and imagination. The pathogenesis of autism is unknown but it is...